BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8196271)

  • 1. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A.
    Burdmann EA; Andoh TF; Rosen S; Lindsley J; Munar MY; Elzinga LW; Bennett WM
    Kidney Int; 1994 Mar; 45(3):684-91. PubMed ID: 8196271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of less chronic nephrotoxicity by cyclosporine G than cyclosporine A in a low-salt rat model.
    Burdmann EA; Rosen S; Lindsley J; Elzinga L; Andoh T; Bennett WM
    Transplantation; 1993 May; 55(5):963-6. PubMed ID: 8497907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
    Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
    J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of cyclosporin A, cyclosporin G, and the novel cyclosporin derivative IMM 125 in isolated glomeruli and cultured rat mesangial cells: a morphometric analysis.
    Potier M; Wolf A; Cambar J
    Nephrol Dial Transplant; 1998 Jun; 13(6):1406-11. PubMed ID: 9641169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs.
    Burdmann EA; Andoh TF; Lindsley J; Russell J; Bennett WM; Porter G
    Ren Fail; 1994; 16(1):161-8. PubMed ID: 7514309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine A versus cyclosporine G: a comparative study of survival, hepatotoxicity, nephrotoxicity, and splenic atrophy in BALB/c mice.
    Masri MA; Naiem M; Pingle S; Daar AS
    Transpl Int; 1988 Apr; 1(1):13-8. PubMed ID: 3254185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley rats.
    Duncan JI; Thomson AW; Simpson JG; Davidson RJ; Whiting PH
    Transplantation; 1986 Oct; 42(4):395-9. PubMed ID: 3765053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity.
    Pere AK; Lindgren L; Tuomainen P; Krogerus L; Rauhala P; Laakso J; Karppanen H; Vapaatalo H; Ahonen J; Mervaala EM
    Kidney Int; 2000 Dec; 58(6):2462-72. PubMed ID: 11115079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and tolerability of cyclosporine G in human kidney transplant recipients.
    Huser B; Thiel G; Oberholzer M; Beveridge T; Bianchi L; Mihatsch MJ; Landmann J
    Transplantation; 1992 Jul; 54(1):65-9. PubMed ID: 1631947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low and high density lipoproteins on renal cyclosporine A and cyclosporine G disposition in the isolated perfused rat kidney.
    Strong ML; Ueda CT
    Pharm Res; 1997 Oct; 14(10):1466-71. PubMed ID: 9358563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture.
    Ellouk-Achard S; Martin C; Pham-Huy C; Duc HT; Thevenin M; Dutertre-Catella H; Warnet JM; Claude JR
    Arch Toxicol; 1997; 71(7):437-42. PubMed ID: 9209689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Previous exposure to cigarette smoke aggravates experimental cyclosporine-induced nephrotoxicity.
    Alves SA; Carlos CP; Mendes GE; Oliveira SM; Luz MA; Souza RP; Matimoto RL; Coimbra TM; Burdmann EA
    Am J Nephrol; 2012; 36(4):334-41. PubMed ID: 23018139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An underlying role for hepatobiliary dysfunction in cyclosporine A nephrotoxicity.
    Aleo MD; Doshna CM; Fritz CA
    Toxicol Appl Pharmacol; 2008 Jul; 230(1):126-34. PubMed ID: 18407308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?
    Kuhn UD; Lupp A; Kostka E; Kühl A; Balogh A; Stein G; Fleck C
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):484-90. PubMed ID: 9784027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of silibinin on experimental cyclosporine nephrotoxicity.
    Zima T; Kameníková L; Janebová M; Buchar E; Crkovská J; Tesar V
    Ren Fail; 1998 May; 20(3):471-9. PubMed ID: 9606735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleterious effect of cyclosporins on the ischemic kidney in the rat and the protection by the calcium antagonist verapamil.
    Ar'Rajab A; Dawidson IJ; Harris RB; Mileski WJ; Sentementes JT
    J Am Soc Nephrol; 1994 Jul; 5(1):93-101. PubMed ID: 7948788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity.
    Schnabel FR; Wait RB; Kahng KU
    Transplantation; 1991 Mar; 51(3):686-9. PubMed ID: 2006526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral magnesium supplementation on acute experimental cyclosporin nephrotoxicity.
    Burdmann EA; Andoh TF; Lindsley J; Houghton DC; Bennett WM
    Nephrol Dial Transplant; 1994; 9(1):16-21. PubMed ID: 8177471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations.
    Podder H; Stepkowski SM; Napoli KL; Clark J; Verani RR; Chou TC; Kahan BD
    J Am Soc Nephrol; 2001 May; 12(5):1059-1071. PubMed ID: 11316866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of cyclosporine A and cyclosporine G in a rat model.
    Tejani A; Lancman I; Pomrantz A; Khawar M; Chen C
    Transplantation; 1988 Jan; 45(1):184-7. PubMed ID: 3336915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.